Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

RedHill Biopharma (RDHL) Return on Equity: 2015-2024

Historic Return on Equity for RedHill Biopharma (RDHL) over the last 10 years, with Dec 2024 value amounting to 6.33%.

  • RedHill Biopharma's Return on Equity was N/A to 0.20% in Q2 2019 from the same period last year, while for Jun 2019 it was 0.20%, marking a year-over-year change of. This contributed to the annual value of 6.33% for FY2024, which is 736.00% up from last year.
  • Per RedHill Biopharma's latest filing, its Return on Equity stood at 6.33% for FY2024, which was up 712.74% from -1.03% recorded in FY2023.
  • Over the past 5 years, RedHill Biopharma's Return on Equity peaked at 6.33% during FY2024, and registered a low of -8.60% during FY2021.
  • In the last 3 years, RedHill Biopharma's Return on Equity had a median value of 3.63% in 2022 and averaged 2.97%.
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by 998bps in 2021, then surged by 1,222bps in 2022.
  • Yearly analysis of 5 years shows RedHill Biopharma's Return on Equity stood at 1.39% in 2020, then crashed by 998bps to -8.60% in 2021, then surged by 1,222bps to 3.63% in 2022, then plummeted by 466bps to -1.03% in 2023, then spiked by 736bps to 6.33% in 2024.